AdjuvantAdsorptionEfficiency_QualityChecker

Adjuvant Adsorption Efficiency

Huvac human vaccines vaccination adjuvants mRNA vaccines sterility endotoxins cold chain
Open selection

Utility description: Adjuvant Adsorption Efficiency

Adjuvant Adsorption Efficiency Quality Checker — Control of Adjuvant Adsorption Efficiency

ℹ️  Utility assesses the degree of antigen binding to aluminum adjuvant (aluminum hydroxide or phosphate) according to Ph. Eur. 5.2.2 and internal vaccine manufacturer standards:
     • Adsorption Efficiency: Calculated as % of antigen bound to adjuvant. Norm: ≥ 90-95%.
     • Free Antigen: Amount of unadsorbed protein in supernatant. Must be minimal.
     • Aluminum Content: Control of adjuvant dose (typically 0.2–0.85 mg Al per dose).
     • pH of Medium: Critical parameter affecting adjuvant surface charge and protein stability.

⚠️  CRITICAL: Low adsorption efficiency (<90%) means a significant part of the antigen will be rapidly cleared from the body without depot formation!
     This leads to reduced vaccine immunogenicity and potential increase in reactogenicity of free protein.

Usage:
  AdjuvantAdsorptionEfficiencyQualityChecker.exe                            → demo mode (console output)
  AdjuvantAdsorptionEfficiencyQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,ProductName,AdjuvantType,TotalAntigen_ug_per_ml,FreeAntigen_ug_per_ml,AluminumContent_mg_per_ml,pH,SeparationMethod

Example:
  ADJ-2026-HEPB-001,HepB Vaccine,AluminiumHydroxide,20.0,0.5,0.5,6.2,Centrifugation

— WHY IS THIS NEEDED?
Aluminum adjuvants work by creating an antigen depot and recruiting immune cells.
If the antigen is not adsorbed, the "depot" mechanism does not work.
Adsorption control is a key step in validating the bulk blending process.

⚠️  CRITICAL:
• Separation Method: To analyze free antigen, it is necessary to carefully separate the adjuvant (by centrifugation or filtration) without disturbing adsorption equilibrium.
• pH: Adsorption is maximal when pH is close to the protein's isoelectric point (IEP) and opposite to the adjuvant's charge.
• Adjuvant Aging: "Old" aluminum particles may have less surface area and bind protein poorly.
• Competition: In multicomponent vaccines, different antigens may compete for binding sites on the adjuvant.

Key features:
• Automatic calculation of adsorption percentage
• Control of free antigen content
• Verification of medium parameters (pH, Al concentration)
• Generation of reports for R&D and QC departments, and LIMS LabWare
• Compliance with Ph. Eur. 5.2.2 and GMP requirements

Critical parameters:
• Adsorption Efficiency: ≥ 90%
• Free Antigen: ≤ 10% of total amount
• Aluminum: within product specification
• pH: 5.5 – 7.0 (typical)

💡 Usage tips:
1. Equilibrium: Allow time for adsorption equilibrium to establish before sampling for analysis.
2. Supernatant Analysis: Ensure no adjuvant particles remain in the supernatant (turbidity check), otherwise free antigen result will be underestimated.
3. Antigen Assay Method: Use specific methods (ELISA, HPLC) that do not react with the adjuvant itself.
4. Temperature Regime: Adsorption may depend on temperature. Perform analysis at standard temperature (20-25°C).
5. Validation: Phase separation method must be validated for completeness of adjuvant precipitation/filtration.

⚠️ Note: Degree of adsorption may change over time during storage (desorption or rearrangement). Therefore, control is performed both at the finished product stage and during stability studies.

input.csv

BatchNumber,ProductName,AdjuvantType,TotalAntigen_ug_per_ml,FreeAntigen_ug_per_ml,AluminumContent_mg_per_ml,pH,SeparationMethod
ADJ-2026-HEPB-001,Hepatitis B Vaccine,AluminiumHydroxide,20.0,0.5,0.5,6.2,Centrifugation
ADJ-2026-DTP-002,DTPa Vaccine,AluminiumPhosphate,100.0,2.0,0.33,5.8,Filtration
ADJ-2026-FAIL-003,Pneumococcal Conj.,AluminiumHydroxide,50.0,15.0,0.5,6.0,Centrifugation

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of AdjuvantAdsorptionEfficiency_QualityChecker for Adjuvant Adsorption Efficiency Quality Checker.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility assesses the degree of antigen binding to aluminum adjuvant (aluminum hydroxide or phosphate) according to Ph. Eur. 5.2.2 and internal vaccine manufacturer standards:
  • • Adsorption Efficiency: Calculated as % of antigen bound to adjuvant. Norm: ≥ 90-95%.
  • • Free Antigen: Amount of unadsorbed protein in supernatant. Must be minimal.
  • • pH of Medium: Critical parameter affecting adjuvant surface charge and protein stability.
  • ⚠️ CRITICAL: Low adsorption efficiency (<90%) means a significant part of the antigen will be rapidly cleared from the body without depot formation!
  • ⚠️ CRITICAL:
  • • pH: Adsorption is maximal when pH is close to the protein's isoelectric point (IEP) and opposite to the adjuvant's charge.
  • • Compliance with Ph. Eur. 5.2.2 and GMP requirements
  • Critical parameters:
  • • Adsorption Efficiency: ≥ 90%
  • • Free Antigen: ≤ 10% of total amount
  • 5. Validation: Phase separation method must be validated for completeness of adjuvant precipitation/filtration.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file for Adjuvant Adsorption Efficiency Quality Checker with headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.HighIdentical input data, rule version and configuration produce reproducible results.
URS-003The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.HighSchema, conversion and range errors are explicitly reported.
URS-004The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.HighEach check has PASS/WARNING/FAIL and a clear message.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall preserve traceability between batch/sample, input file, applied rules and final status.HighOutput contains identifiers, checked parameters and audit metadata.
URS-007The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.MediumURS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.MediumDocumentation states change control and limit-verification expectations.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstring / controlled vocabularyADJ-2026-HEPB-001Batch or lot identifier used for traceability.
2ProductNamestring / controlled vocabularyHepatitis B VaccineProduct or dosage-form name under evaluation.
3AdjuvantTypestring / controlled vocabularyAluminiumHydroxideControlled input parameter for deterministic QC rules.
4TotalAntigen_ug_per_mldecimal20.0Volume/dose used for load, limit or release calculation.
5FreeAntigen_ug_per_mldecimal0.5Volume/dose used for load, limit or release calculation.
6AluminumContent_mg_per_mldecimal0.5Volume/dose used for load, limit or release calculation.
7pHdecimal6.2pH; parameter relevant to stability, compatibility and batch suitability.
8SeparationMethodstring / controlled vocabularyCentrifugationComponent ratio; structural or formulation CQA.
BatchNumber,ProductName,AdjuvantType,TotalAntigen_ug_per_ml,FreeAntigen_ug_per_ml,AluminumContent_mg_per_ml,pH,SeparationMethod
ADJ-2026-HEPB-001,Hepatitis B Vaccine,AluminiumHydroxide,20.0,0.5,0.5,6.2,Centrifugation
ADJ-2026-DTP-002,DTPa Vaccine,AluminiumPhosphate,100.0,2.0,0.33,5.8,Filtration
ADJ-2026-FAIL-003,Pneumococcal Conj.,AluminiumHydroxide,50.0,15.0,0.5,6.0,Centrifugation

Input validation rules

IDFieldRuleCriticality
VR-001BatchNumberThe field shall match an approved dictionary or accepted string representation.High
VR-002ProductNameThe field shall match an approved dictionary or accepted string representation.High
VR-003AdjuvantTypeThe field shall match an approved dictionary or accepted string representation.High
VR-004TotalAntigen_ug_per_mlThe field shall match an approved dictionary or accepted string representation.Medium
VR-005FreeAntigen_ug_per_mlThe field shall match an approved dictionary or accepted string representation.Medium
VR-006AluminumContent_mg_per_mlThe field shall match an approved dictionary or accepted string representation.Medium
VR-007pHThe field shall match an approved dictionary or accepted string representation.Medium
VR-008SeparationMethodThe field shall match an approved dictionary or accepted string representation.Medium

FS — Functional Specification

IDFunctionImplementation
FS-001CLI executionSupport execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002CSV importRead input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003Schema validationCheck mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004Type conversionConvert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005Domain rule engineApply rules for Adjuvant Adsorption Efficiency Quality Checker, including critical limits from the description and approved specification.
FS-006Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008Audit supportKeep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009Integration contractSupport the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010Error handlingReturn explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "adjuvantadsorptionefficiency-qualitychecker",
  "utilityFolder": "AdjuvantAdsorptionEfficiency_QualityChecker",
  "package": "huvac",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "ADJ-2026-HEPB-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "ProductName",
      "value": "Hepatitis B Vaccine",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "AdjuvantType",
      "value": "AluminiumHydroxide",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "TotalAntigen_ug_per_ml",
      "value": "20.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "FreeAntigen_ug_per_ml",
      "value": "0.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "AluminumContent_mg_per_ml",
      "value": "0.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "pH",
      "value": "6.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "SeparationMethod",
      "value": "Centrifugation",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "AdjuvantAdsorptionEfficiency_QualityChecker.documentation.html"
  }
}

Traceability matrix

URSFSTestEvidence
URS-001FS-001, FS-002OQ-001Verify execution and import of valid input.csv.
URS-002FS-005, FS-006OQ-004Repeat the same dataset and compare output.json.
URS-003FS-003, FS-004, FS-010OQ-002, OQ-003Verify missing columns and invalid types.
URS-004FS-005, FS-006OQ-004, PQ-001Verify critical deviations on real/boundary data.
URS-005FS-007, FS-009OQ-005Verify JSON schema and downstream-system suitability.
URS-006FS-008OQ-006Verify identifiers and audit metadata.
URS-007FS-008, FS-010IQ-001, OQ-007Verify documentation completeness and control evidence.
URS-008FS-005, FS-008PQ-002Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

IDScenarioExpected result
IQ-001Verify executable, input.csv, documentation and checksum availability.Delivery set is complete; version is recorded.
OQ-001Valid sample row from input.csv.PASS or acceptable WARNING according to rules.
OQ-002Remove a mandatory CSV column.Schema error or FAIL with missing-column reference.
OQ-003Place a non-numeric value into a numeric field.Type-conversion error with row/field reference.
OQ-004Set a critical parameter outside the limit.FAIL and critical finding.
OQ-005Verify output.json structure.All mandatory sections are present and JSON is valid.
OQ-006Verify batch/sample traceability.Input and result identifiers match.
PQ-001Verify 3–5 real user batches/samples.Result is confirmed by QC/QA review.
PQ-002Verify deviation workflow and manual QA decision.Utility supports review but does not replace approved decision.

QA/QC and change control

  • Do not rename columns without updating validator, documentation and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
  • The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Huvac — Human Vaccine QC Utilities

Huvac contains QC utilities for human vaccines: adjuvants, antigen potency, sterility, endotoxins, cold chain, mRNA controls, container closure and stability checks.

Open